Cellics Therapeutics INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersSan Diego, CA
US patents4
SAM.gov UEIFA3EB44NCGN3
CAGE code8AXT3
Incorporated inDE
Supplier designations
For Profit OrganizationManufacturer of GoodsMinority Owned BusinessWoman Owned BusinessWoman Owned Small Business
Self-certified by the company in its SAM.gov registration
Patents
4 US patents granted 2019–2025, 3 of them in the five years to SEP 2025.
Pharmaceuticals 3Measurement 1
- Nanoparticles containing cellular membrane and uses thereofUS 12,350,381 · granted JUL 8, 2025
- Methods and compositions for quantifying hemoglobinUS 11,353,466 · granted JUN 7, 2022
- Use of nanoparticles coated with red blood cell membranes to treat hemolytic diseases and disordersUS 11,110,127 · granted SEP 7, 2021
- Use of nanoparticles coated with red blood cell membranes to enable blood transfusionUS 10,434,070 · granted OCT 8, 2019
Granted to Cellics Therapeutics INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Cellics Therapeutics INC | San Diego | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.